{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:32:48Z","timestamp":1762432368205},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,16]]},"DOI":"10.7759\/cureus.48880","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T09:49:20Z","timestamp":1700128160000},"source":"Crossref","is-referenced-by-count":3,"title":["Challenging Diagnosis of Lytic Bone Lesions Between Multiple Myeloma and Bone Metastasis of Primary Breast Cancer"],"prefix":"10.7759","author":[{"given":"Tao","family":"Edahiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ureshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsumi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyasu","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy GR","year":"2002","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002, 2:584-93. 10.1038\/nrc867","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: challenges and approaches, a review","volume":"2","author":"Vogt A","year":"2017","unstructured":"Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017, 2:e000172. 10.1136\/esmoopen-2017-000172","journal-title":"ESMO Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005288","article-title":"Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial","volume":"136","author":"Voorhees PM","year":"2020","unstructured":"Voorhees PM, Kaufman JL, Laubach J, et al.. Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial. Blood. 2020, 136:936-45. 10.1182\/blood.2020005288","journal-title":"Blood"},{"key":"ref5","article-title":"A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma","volume":"87","author":"Corso A","year":"2002","unstructured":"Corso A, Arcaini L, Caberlon S, et al.. A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma. Haematologica. 2002, 87:1041-5.","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-204368","article-title":"Hypercalcaemia of malignancy: two primaries in the same patient","volume":"2014","author":"Trisal D","year":"2014","unstructured":"Trisal D, Kumar N, Sundriyal D, Gadpayle AK. Hypercalcaemia of malignancy: two primaries in the same patient. BMJ Case Rep. 2014, 2014:10.1136\/bcr-2014-204368","journal-title":"BMJ Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF02482821","article-title":"Multiple myeloma mimicking bone metastasis from breast cancer: report of a case","volume":"28","author":"Tomono H","year":"1998","unstructured":"Tomono H, Fujioka S, Kato K, et al.. Multiple myeloma mimicking bone metastasis from breast cancer: report of a case. Surg Today. 1998, 28:1304-6. 10.1007\/BF02482821","journal-title":"Surg Today"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2017.11.001","article-title":"Breast cancer and synchronous multiple myeloma as a diagnostic challenge: Case report and review of literature","volume":"42","author":"Soko\u0142owski M","year":"2018","unstructured":"Soko\u0142owski M, Mazur G, Butrym A. Breast cancer and synchronous multiple myeloma as a diagnostic challenge: Case report and review of literature. Curr Probl Cancer. 2018, 42:231-4. 10.1016\/j.currproblcancer.2017.11.001","journal-title":"Curr Probl Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016","volume":"4","author":"Cowan AJ","year":"2018","unstructured":"Cowan AJ, Allen C, Barac A, et al.. Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016. JAMA Oncol. 2018, 4:1221-7. 10.1001\/jamaoncol.2018.2128","journal-title":"JAMA Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2017.715","article-title":"Bone metastasis risk factors in breast cancer","volume":"11","author":"Pulido C","year":"2017","unstructured":"Pulido C, Vendrell I, Ferreira AR, Casimiro S, Mansinho A, Alho I, Costa L. Bone metastasis risk factors in breast cancer. Ecancermedicalscience. 2017, 11:715. 10.3332\/ecancer.2017.715","journal-title":"Ecancermedicalscience"},{"key":"ref11","article-title":"Bone metastasis: evaluation of 1100 patients with breast cancer","volume":"14","author":"Ba\u015fdelio\u011flu K","year":"2021","unstructured":"Ba\u015fdelio\u011flu K. Bone metastasis: evaluation of 1100 patients with breast cancer. Int J Clin Exp Pathol. 2021, 14:338-47.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck AT","year":"2010","unstructured":"Stopeck AT, Lipton A, Body JJ, et al.. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010, 28:5132-9. 10.1200\/JCO.2010.29.7101","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje N","year":"2018","unstructured":"Raje N, Terpos E, Willenbacher W, et al.. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol. 2018, 19:370-81. 10.1016\/S1470-2045(18)30072-X","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2021.59376","article-title":"Differentiation of multiple myeloma and metastases with apparent diffusion coefficient map histogram analysis","volume":"9","author":"Baykara M","year":"2022","unstructured":"Baykara M, Yildirim M. Differentiation of multiple myeloma and metastases with apparent diffusion coefficient map histogram analysis. North Clin Istanb. 2022, 9:256-60. 10.14744\/nci.2021.59376","journal-title":"North Clin Istanb"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan AJ","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, et al.. Diagnosis and management of multiple myeloma: a review. JAMA. 2022, 327:464-77. 10.1001\/jama.2022.0003","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-00650-4","article-title":"Validation of the revised 8th AJCC breast cancer clinical prognostic staging system: analysis of 5321 cases from a single institution","volume":"34","author":"Aldrees R","year":"2021","unstructured":"Aldrees R, Gao X, Zhang K, Siegal GP, Wei S. Validation of the revised 8th AJCC breast cancer clinical prognostic staging system: analysis of 5321 cases from a single institution. Mod Pathol. 2021, 34:291-9. 10.1038\/s41379-020-00650-4","journal-title":"Mod Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15163","article-title":"Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine","volume":"112","author":"Shimazu Y","year":"2021","unstructured":"Shimazu Y, Mizuno S, Fuchida SI, et al.. Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine. Cancer Sci. 2021, 112:5034-45. 10.1111\/cas.15163","journal-title":"Cancer Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/201673-challenging-diagnosis-of-lytic-bone-lesions-between-multiple-myeloma-and-bone-metastasis-of-primary-breast-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:45Z","timestamp":1707509505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/201673-challenging-diagnosis-of-lytic-bone-lesions-between-multiple-myeloma-and-bone-metastasis-of-primary-breast-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.48880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}